Arcus Biosciences Inc
RCUS
$24.41+2.43%
End of day · as of Oct 11, 2026, 8:01 AM ET
Mkt cap
$885.20M
EV/Sales
3.09
P/E ratio
N/A
FY2025 Revenue
$247.00M
EPS (TTM)
$-3.94
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-142.91%
Beta
0.83
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
Latest reported RCUS revenue for 2025-12-31 was $247.0M. Net income was -$353.0M. Revenue was down 4.3% from 2024-12-31 to 2025-12-31. RCUS currently screens at market cap $885.2M.
Use this RCUS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full RCUS income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Arcus Biosciences Inc (RCUS) is a biotechnology company in the Healthcare sector.
Latest cached Arcus Biosciences Inc (RCUS) revenue for Dec 31, 2025 was $247.0M. Net income was -$353.0M. Statements: https://lician.com/financials/rcus
Arcus Biosciences Inc (RCUS) market capitalization is $885.2M on the latest cached snapshot.
Arcus Biosciences Inc (RCUS) cached previous close $23.83; day range $23.75 – $24.58; volume 795,184. Session quote: https://lician.com/quote/rcus